首页 | 本学科首页   官方微博 | 高级检索  
     


Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour
Authors:Aline-Cristina-Batista-Rodrigues Johann  Patrícia-Carlos Caldeira  Marcelo-Vidigal Caliari  Ricardo-Santiago Gomez  Maria-Cássia-Ferreira Aguiar  Ricardo-Alves Mesquita
Affiliation:1.DDS, PhD. Pontifícia Universidade Católica do Paraná, School of Health and Biosciences, Curitiba, PR, Brazil;2.DDS, PhD. DDS, PhD. DDS, PhD. DDS, PhD. Department of Oral Surgery and Oral Pathology, School of Dentistry, Universidade Federal de Minas Gerais;3.PhD Department of Pathology, Biological Sciences Institute, Universiade Federal de Minas Gerais
Abstract:

Background

To compare the metallothionein (MT) immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour (KOT), to correlate MT with cellular proliferation, and to evaluate the influence of inflammation in MT.

Material and Methods

Fourteen cases of KOT were submitted to immunohistochemistry for MT and Ki-67 analysis. The lesions were grouped according to their grade of inflammation, and statistical analysis was performed.

Results

MT was higher in non-syndromic KOT than in syndromic KOT (p<0.05). No statistical difference in Ki-67 could be identified; however, an inverse correlation was observed between MT and Ki-67 in both lesions. When analysing inflammation, non-syndromic KOT showed no differences in either MT or Ki-67.

Conclusions

The MT immunophenotype of syndromic KOT was different from non-syndromic KOT. MT might not be involved in the proliferation control of both KOT. MT and Ki-67 immunoexpressions proved to be unaffected by inflammation in non-syndromic KOT.Key words:Odontogenic tumours, basal cell nevus syndrome, metallothionein, Ki-67 Antigen, immunohistoche-mistry.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号